Focus Partners Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Focus Partners Wealth's LLY Position: Q1 2026 in Review
Focus Partners Wealth increased its Eli Lilly (LLY) stake by 6.7% in Q1 2026, buying an estimated $15.1M and bringing the position to 237,125 shares worth $218M. The position accounts for 0.24% of the portfolio, ranked #91.
Focus Partners Wealth first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $237M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Focus Partners Wealth held 237,125 shares of Eli Lilly worth $218M as of Q1 2026.
- Focus Partners Wealth bought 14,883 Eli Lilly shares in Q1 2026, an estimated $15.1M.
- Eli Lilly made up 0.24% of Focus Partners Wealth's portfolio in Q1 2026, its #91 holding.
- Focus Partners Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
- Focus Partners Wealth's Eli Lilly position peaked at $237M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.